Skip to content
WeighLab
Not scored: not available to order

SHRED Review: Pros & Cons

By The WeighLab Bench, Tools & Data Desk

SHRED is a strength and fitness app with coach-built plans that adapt to your equipment; it isn't a prescriber and doesn't sell GLP-1 medication.

Not available to order

SHRED is a workout-planning app. It doesn't prescribe or sell GLP-1 medication.

Looking for a GLP-1 program you can start online? See the cheapest GLP-1 providers or the leaderboard.

Where the value is

  • Coach-built training plans that adjust to your equipment and progress
  • Tracks weights, reps and personal bests
  • Works with dumbbells, barbells, bands or bodyweight only

The tradeoffs

  • It doesn't prescribe or sell semaglutide, tirzepatide or any GLP-1 medication
  • It's a fitness app, not a medical service
  • Pricing isn't shown on the homepage

The bottom line

Best for: People who want a structured workout plan, not a weight-loss prescription. SHRED is a strength and fitness app with coach-built plans that adapt to your equipment; it isn't a prescriber and doesn't sell GLP-1 medication.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

GLP-1 programs you can start online

These are partners: we may earn a commission if you sign up, at no cost to you.

  • Peter MDPartner

    Semaglutide from $149/mo · tirzepatide from $249/mo

    One account across six verticals — TRT, ED, weight loss, GLP-1, men's hair loss and NAD+ — from a physician-prescribed telehealth brand running since 2021, at a renewal price ($249/mo tirzepatide) well above its own $149 first-month headline.

  • Gala HealthPartner

    Tirzepatide from $179/mo

    Every dose at one published price, with the whole price list visible before you hand over an email — but the only terms it sells on are a yearly subscription at $179 or a three-month plan at $199, so there is no monthly number here to compare with anyone else's.

  • Direct MedsPartner

    Semaglutide from $249/mo · tirzepatide from $299/mo

    Direct Meds sells semaglutide and tirzepatide both as a sublingual and as an injection, every product priced in the open, from $249 a month on a plan that bills against a 90-day supply.

Compare with other providers

More GLP-1 providers we have reviewed. See the alternatives to SHRED.

The 19 programs nearest this one

Pricing, states and verification reflect SHRED's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on SHRED's site. Not medical advice; see our disclosure.

← Back to the value leaderboard